Gold nanoparticles enhance the effect of tyrosine kinase inhibitors in acute myeloid leukemia therapy

BACKGROUND AND AIMS: Every year, in Europe, acute myeloid leukemia (AML) is diagnosed in thousands of adults. For most subtypes of AML, the backbone of treatment was introduced nearly 40 years ago as a combination of cytosine arabinoside with an anthracycline. This therapy is still the worldwide sta...

Descripción completa

Detalles Bibliográficos
Autores principales: Petrushev, Bobe, Boca, Sanda, Simon, Timea, Berce, Cristian, Frinc, Ioana, Dima, Delia, Selicean, Sonia, Gafencu, Grigore-Aristide, Tanase, Alina, Zdrenghea, Mihnea, Florea, Adrian, Suarasan, Sorina, Dima, Liana, Stanciu, Raluca, Jurj, Ancuta, Buzoianu, Anca, Cucuianu, Andrei, Astilean, Simion, Irimie, Alexandru, Tomuleasa, Ciprian, Berindan-Neagoe, Ioana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4760658/
https://www.ncbi.nlm.nih.gov/pubmed/26929621
http://dx.doi.org/10.2147/IJN.S94064

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4760658/
https://www.ncbi.nlm.nih.gov/pubmed/26929621
http://dx.doi.org/10.2147/IJN.S94064

Ejemplares similares